A Prospective Virtual Study to Evaluate the Longevity of IgG Antibodies in Individuals Exposed to COVID-19

NCT05042193 · clinicaltrials.gov ↗

COMPLETED

Status

1883

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2 Acute Respiratory Disease

Interventions

OTHER: SARS-CoV-2

Sponsor

Everly Health